Repligen
RGEN
#1859
Rank
A$16.07 B
Marketcap
A$251.51
Share price
2.97%
Change (1 day)
12.20%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of June 2026 : A$4.27 Billion

According to Repligen 's latest financial reports the company's total assets are A$4.27 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$4.14 B11.74%
2022-12-31A$3.70 B14.05%
2021-12-31A$3.25 B31.45%
2020-12-31A$2.47 B23.75%
2019-12-31A$1.99 B81.87%
2018-12-31A$1.09 B15.46%
2017-12-31A$0.95 B137.61%
2016-12-31A$0.40 B99.67%
2015-12-31A$0.20 B28.05%
2014-12-31A$0.15 B17.85%
2013-12-31A$0.13 B42.49%
2012-12-31A$93.35 M
2011-03-31A$69.95 M-9.82%
2010-03-31A$77.57 M-26.48%
2009-03-31A$0.10 B41.17%
2008-03-31A$74.74 M107.69%
2007-03-31A$35.98 M-11.18%
2006-03-31A$40.51 M13.42%
2005-03-31A$35.72 M-9.11%
2004-03-31A$39.3 M-11.5%
2003-03-31A$44.41 M-18.6%
2002-03-31A$54.56 M-17.97%
2001-03-31A$66.51 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
A$291.57 B 6,717.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$164.06 B 3,736.17%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$184.39 B 4,211.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$128.69 B 2,909.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$86.93 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.38 B-67.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$7.76 B 81.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$3.74 B-12.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$16.99 B 297.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$10.91 B 155.31%๐Ÿ‡บ๐Ÿ‡ธ USA